Pharmafile Logo

long-term condition

- PMLiVE

The science of experience planning in pharma media

Our digital lead, Richard Springham, looks at how the principles of behavioural science and experience planning are used in best practice pharma media planning.

Four Agency Worldwide

- PMLiVE

Who will be the new disrupter of HCP media

Our digital lead, Richard Springham, looks at the move of the tech behemoths and the impact on HCP media.

Four Agency Worldwide

Why I think rare disease companies are more patient-centric

Guest blogger Kamlesh Sheth believes companies that specialise in rare disease tend to be more patient-centric.

Say Communications

Roche Basel Switzerland

Roche claims its own CAR-T first with orphan drug Actemra

Comes as FDA approves the first CAR-T therapy from Novartis

- PMLiVE

Turnstone Biologics bolsters leadership team

Kris Elverum and José Otero join the group

- PMLiVE

Proving real-world value

A focus on the industry

- PMLiVE

FDA clears Teva’s tardive dyskinesia drug Austedo

The twice-daily drug will compete with Neurocrine Bioscience’s Ingrezza

- PMLiVE

NICE backs Allergan’s IBS therapy Truberzi

The £3 per day therapy was recommended in final guidance from the cost-effectiveness watchdog

Empathology: The science of being someone else

If you can see the world from your customer's perspective, you have discovered the secret of empathy

Life Healthcare Communications

How to be a patient

Doctors are trained on how to manage their patients. Now Which? magazine has published a guide for patients on how to get the most out of their GP

Life Healthcare Communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links